FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AZOR, the brand-name combination of amlodipine besylate and olmesartan medoxomil, by Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AZOR (Amlodipine besylate and olmesartan medoxomil)

Snippet

SUPPL AP for AZOR (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)